| 指标 | 高危腺瘤组 (n = 86, 20.72%) | 非高危腺瘤组 (n = 329, 79.28%) | p值 |
| 性别 |
|
| <0.05 |
| 男 | 68 (25.19%) | 202 (74.81%) |
|
| 女 | 18 (12.41%) | 127 (87.59%) |
|
| 年龄 | 57.02 ± 9.48 | 51.83 ± 9.48 | <0.05 |
| BMI | 25.53 ± 3.58 | 25.62 ± 3.45 | >0.05 |
| 吸烟史 |
|
| >0.05 |
| 是 | 31 (24.60%) | 95 (75.40%) |
|
| 否 | 55 (19.03%) | 234 (80.97%) |
|
| 饮酒史 |
|
| >0.05 |
| 是 | 26 (23.85%) | 83 (76.15%) |
|
| 否 | 60 (19.61%) | 246 (80.39%) |
|
| 高血压 |
|
| >0.05 |
| 是 | 31 (24.60%) | 95 (75.40%) |
|
| 否 | 55 (19.03%) | 234 (80.97%) |
|
| 糖尿病 |
|
| >0.05 |
| 是 | 10 (18.18%) | 45 (81.82%) |
|
| 否 | 76 (21.11%) | 284 (78.89%) |
|
| 结直肠癌家族史 |
|
| <0.05 |
| 是 | 10 (45.45%) | 12 (54.55%) |
|
| 否 | 76 (19.34%) | 317 (80.66%) |
|
| AFP | 2.99 (2.39~3.98) | 3.01 (2.21~4.22) | >0.05 |
| CEA | 2.33 (1.36~3.19) | 1.77 (1.16~2.64) | >0.05 |
| CA19-9 | 8.25 (5.23~13.66) | 9.49 (6.35~14.8) | >0.05 |
| 血红蛋白 | 148.21 ± 15.45 | 145.56 ± 15 | >0.05 |
| SII | 412.79 (275.7~564.19) | 352.48 (259.66~504.85) | >0.05 |
| NLR | 1.95 (1.27~2.21) | 1.58 (1.22~2.03) | <0.05 |
| PLR | 114.88 (88.36~143.33) | 117.39 (92.31~142.27) | >0.05 |
| TBIL | 16.49 (10.89~23.53) | 16.67 (12.5~20.97) | >0.05 |
| DBIL | 4.62 (3.31~7.05) | 3.72 (2.77~5.3) | <0.05 |
| IBIL | 10.74 (7.62~16.5) | 12.8 (9.15~16.16) | >0.05 |
| TC | 4.88 ± 1.03 | 5.15 ± 1.04 | <0.05 |
| TG | 1.37 (0.98~1.97) | 1.35 (0.98~2.07) | >0.05 |
| HDL | 1.41 ± 0.45 | 1.48 ± 0.51 | >0.05 |
| LDL | 2.89 ± 0.84 | 3.01 ± 0.79 | >0.05 |